OBJECTIVE: To investigate the relationship between polymorphisms in the OB-R and OB genes and metabolic markers for obesity and glucose intolerance in a population of Nauruan men. In addition, we examined the effect of the simultaneous presence of the three polymorphisms on the phenotype of individuals in this population. DESIGN AND SUBJECTS: This study was conducted in a population from the Paci®c Island of Nauru. Populations in this region have some of the highest recorded rates of obesity and type 2 diabetes and are therefore of great interest in the genetic analysis of these diseases. Two hundred and thirty-two male subjects were examined in this crosssectional study. All subjects were non-diabetic and the group had a mean age of 31 y and a mean body weight of 104 kg. MEASUREMENTS: Several phenotypic measures of body fatness and fat distribution (anthropometry), fasting plasma insulin, glucose and leptin concentrations, blood pressure and 2 h plasma glucose concentration, genotypes of subjects for the Gln223Arg, PRO1019pro (OB-R gene) and OB gene polymorphisms. RESULTS: Individually, the OB gene and Gln223Arg OB-R polymorphisms were not associated with the obese or glucose-intolerant phenotype in this population. Individuals with the PRO1019pro polymorphism were found to have elevated insulin concentrations and diastolic blood pressure (P c 0.04). In addition, individuals found to simultaneously exhibit homozygosity of the common allele of all three polymorphisms (genotypes: ArgaArg, proapro and IIaII) exhibited signi®cantly elevated fasting insulin levels (P c 0.03). CONCLUSIONS: Paci®c Island populations exhibit a remarkably high prevalence rate of obesity and type 2 diabetes and represent a unique population for genetic studies of obesity. In the present study we have revealed that a speci®c combination of alleles in OB and OB-R, two candidate genes for obesity, may confer an increased risk for the development of insulin resistance in Nauruan males.
Introduction
Obesity is frequently associated with the development of type 2 diabetes (or non-insulin-dependent diabetes mellitus) in many populations 1, 2 and although environmental factors are important in the development of both type 2 diabetes and obesity, it is clear that a genetic predisposition to these diseases is also important. 3 The predisposition to these diseases is thought to be conferred by a number of different genes which may themselves have only minor effects but when present together, these genes may combine to have a pathophysiological effect. 4 The recent identi®cation and development of polymorphic markers within candidate genes, and associations of alleles at candidate loci has proved an informative and practical method for analysing polygenic quantitative traits in animal models and human populations. 5 ± 8 Studies conducted in rodent models of obesity have demonstrated that mutations in either the OB gene (obaob mice) or OB-R, the leptin receptor gene (dbadb mice, Zucker faafa rats, Koletsky rat), result in an obese phenotype with obesity-related complications such as type 2 diabetes. 9 ± 12 A defect in the OB gene is unlikely to represent a major cause of obesity in humans as often obese individuals have very high circulating levels of leptin, the OB gene product. 13, 14 In rare cases however, OB mutations in the homozygous form may result in severe leptin de®ciency and obesity. 15, 16 A novel highly polymorphic marker within the OB gene has also been discovered which may provide an informative tool for association and linkage studies of the OB gene with obesity and type 2 diabetes. 17 The human leptin receptor gene has also received wide-spread attention in the search for obesity-causing mutations in humans. Several polymorphisms in both the introns and exons of OB-R have been identi®ed and investigated in populations exhibiting different prevalence rates of obesity and diabetes, however, this gene does not appear to be a major determinant of these diseases in humans. 18 ± 20 Recently, a rare mutation in exon 16 of OB-R was identi®ed in humans. This alteration was found to result in morbid obesity and endocrine abnormalities in individuals homozygous for the mutation. 21 Obesity is extremely common on the Paci®c island of Nauru, with 64% of men and 69% of women having a BMI greater than 30 kgam 2 . 22 Furthermore, approximately one-third of adult Nauruans also develop type 2 diabetes. 22 In addition to the remarkably high prevalence rates of these two diseases, Nauru is one of the most isolated of Paci®c islands. This geographic isolation is thought to play a role in the rise to epidemic proportions of debilitating diseases on the Island, and thus Nauru offers a unique population for genetic studies into the underlying causes of obesity, and subsequently type 2 diabetes. Recently, studies examining the role of leptin in obesity and type 2 diabetes in Nauru found that, as in other populations, circulating leptin levels were strongly associated with adiposity. 23 In the present study, we examined two of the ®rst available OB-R polymorphisms (Gln223Arg and PRO1019pro) and a polymorphic microsatellite marker in the OB gene to investigate associations of these candidate genes with metabolic markers of obesity and glucose intolerance in a population of men from Nauru. In addition, we have investigated the presence of any additive effect of these markers on the phenotypes examined.
Methods

Subjects
The subjects examined in this study were non-diabetic Nauruan males (n 232) with a mean age of 31 y, a mean body weight of 104 kg (range: 59 ± 200 kg) and a mean BMI of 37 kgam 2 (range: 22 ± 61). Blood samples were collected as part of a population-based survey conducted in Nauru in 1994 which formed the basis of a 7 y follow-up to a survey conducted in 1987. 24 This work is a continuation of a study originating in 1975a1976. 25, 26 The survey protocol was approved by the Alfred Healthcare Group Ethics Committee (Melbourne, Australia) and a written agreement with the Republic of Nauru has been reached for the genetic analysis of samples.
Metabolic measurements
Procedures for data collection in this survey were similar to procedures followed in earlier surveys and described in detail elsewhere. 26 Serum collected in the fasting state was used to measure insulin and leptin. Glucose concentration was measured in plasma collected before and 2 h after an oral glucose load (75 g).
Plasma glucose was measured on-site using a YSI Glucose Analyser (Yellow Springs Instrument Co., Ohio, USA). Insulin and leptin were measured by RIA (Amersham, UK and Linco, St Louis, MO, USA, respectively).
Polymerase chain reaction (PCR)-restriction fragmentlength polymorphism (RFLP)
Genomic DNA was extracted from whole blood stored at the time of collection (Wizard 1 Genomic DNA Puri®cation Kit, Promega Corporation, Madison, WI, USA), and used for subsequent analyses. PCR-RFLP analysis was performed using published oligonucleotide sequences and PCR conditions to amplify the regions of interest within the appropriate genes. 17, 19 The PCR products were then digested using Hae III and Nco I for the Gln223Arg and PRO1019pro polymorphisms, respectively. All PCR products were analysed by agarose gel electrophoresis and visualised using ethidium bromide.
Two available OB-R polymorphisms (Gln223Arg and PRO1019pro) and a single OB gene polymorphism were analysed in this study. All three polymorphisms were genotyped using published conditions. 17, 19 The OB gene polymorphism is a simple tandem repeat polymorphism in the 3
H¯a nking region in the genomic sequence of the human OB gene. This polymorphism produces two classes of products after PCR ampli®ca-tion, a shorter (class I) form with fewer tetranucleotide repeats (121 ± 145 bp), and a longer (class II) form, with more tetranucleotide repeats (197 ± 225 bp). 17 Individuals were grouped into three groups, depending on the sizes of the PCR products, with subjects homozygous for the shorter form designated genotype IaI, subjects with both the longer and shorter alleles designated heterozygotes, IaII, and subjects homozygous for the longer form designated IIaII.
As the numbers of subjects for some genotypes were limited, some grouping was undertaken. Subjects with the IaI (n 5) and IaII (n 38) genotypes were pooled and compared to subjects with the IIaII (n 189) genotype for the OB gene polymorphism. Subjects with the PROaPRO (n 8) and PROapro (n 79) genotypes were pooled and compared to subjects with the proapro (n 145) genotype. As there were no subjects with the GlnaGln genotype, subjects with the GlnaArg (n 52) were compared to those with the ArgaArg (n 180) genotype.
To examine the existence of any additive effect between the three polymorphisms, individuals homozygous for the common allele for all three polymorphisms (ArgaArg, proapro and ClassIIaclassII) were grouped. This group was then compared to the remainder of the subjects, who had all other genotype combinations for these polymorphisms.
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Statistical analysis
Logarithmic transformations were used to normalise distributions of leptin, glucose and insulin and used in all analyses for these variables. The unpaired t-test was used to examine differences between the groups and a Bonferroni correction was used to determine the level of signi®cance after adjusting for the use of multiple tests (P C -corrected P-value). A chi-squared test was used to test for the presence of HardyWeinberg equilibrium amongst the genotypes and the presence of linkage disequilibrium between the OB-R polymorphisms.
Results
The allele and genotype frequencies determined using PCR-RFLP analysis of the Gln223Arg and PRO1019pro OB-R polymorphisms and the OB gene microsatellite polymorphism are shown in Table 1 . The genotype frequencies for all polymorphisms were found to be in Hardy-Weinberg equilibrium and the two OB-R polymorphisms were found to be in linkage disequilibrium (P 0.002). Tables 2 and 3 show that the Gln223Arg and OB gene polymorphisms were not signi®cantly associated with obesity (body weight, BMI or plasma leptin concentration) or parameters of risk of type 2 diabetes (fasting plasma glucose, 2 h glucose or fasting insulin concentration) in this population.
Individuals homozygous for pro allele of the PRO1019pro polymorphism appeared to have higher fasting insulin and leptin concentrations (P 0.02 and P 0.03, respectively), and diastolic blood pressure (P 0.02; Table 4 ). After applying a Bonferroni correction for multiple tests, the association between this allele and both fasting insulin and diastolic blood pressure remained (P C 0.04 for both). Table 5 shows that when individuals homozygous for the more common allele for all three polymorphisms were grouped (genotypes: ArgaArg, proapro and IIaII), this group had signi®cantly higher fasting insulin and leptin concentrations (P 0.002 and P 0.03, respectively) compared to the subjects with all other genotype combinations. After applying a Bonferroni correction for multiple tests, this group were found to have elevated fasting insulin concentrations (P C 0.032; Table 5 , Figure 1 ). 
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Discussion
Individually, the OB gene and Gln223Arg polymorphisms were not associated with the obese or prediabetic phenotype in this population of Nauruan males. There was an association between the PRO1019pro polymorphism and elevated insulin concentrations and diastolic blood pressure. In addition, individuals with homozygosity for the common alleles of all three polymorphisms exhibited signi®cantly higher fasting insulin concentrations than individuals without the polymorphisms. The allele frequencies for the three polymorphisms investigated were compared to frequencies observed in several other populations. In a Japanese cohort, the longer, group II alleles for the OB gene microsatellite polymorphism were found to be present at a frequency of approximately 74%. 17 In the Nauruan population the frequency of this group of alleles was 90%.
A frequency of 89% was observed for Arg allele of the Gln223Arg polymorphism in the Nauruan subjects. This is not dissimilar from previous studies conducted in Japanese and Pima Indian populations where the frequency of this allele was found to be approximately 85% and 75%, respectively. 18, 20 It is however, somewhat higher than the frequency reported for British males, 44%. 19 The frequency of the pro allele for the PRO1019pro polymorphism, approximately 80%, also appears to be similar in the Nauruan population to that seen in other populations. Frequencies of 88% and 85% were observed for this allele in Japanese and Pima Indian populations, respectively, 18, 20 however, once again the frequency in the Nauruan population was higher than that reported for the British population, 36%. 19 The lack of association between the Gln223Arg polymorphism and obesity or risk factors for diabetes is consistent with earlier studies in British males, Caucasians and Japanese subjects. 19, 20, 27 In white British males, no association was observed between the genotype at polymorphic sites in OB-R and obesity or obesity-related phenotypes. 19 A similar lack of association was demonstrated in a cohort of Caucasians and Japanese subjects. 20, 27 The PRO1019pro polymorphism was found to be associated with several markers of obesity and type 2 diabetes in this Nauruan population. Several earlier studies failed to ®nd an association between this polymorphism and obesity. 19, 20 However, one study conducted in Pima Indians found that the pro allele was present exclusively in obese subjects and was associated with differences in percent body fat. 18 Similar to the Nauruan population, Pima Indians have been shown to have remarkably high prevalence rates of obesity and type 2 diabetes.
It was surprising to ®nd an association between the PRO1019pro polymorphism and fasting insulin concentrations and diastolic blood pressure, as this association was not present when subjects were grouped according to the Gln223Arg polymorphism, and these two OB-R polymorphisms were found to be in linkage disequilibrium in this Nauruan population. Although this was unexpected, examination of these same OB-R polymorphisms in a Pima Indian population had shown that although the PRO1019pro and Gln223Arg polymorphisms were in linkage disequilibrium, the allele frequency for the Gln223Arg polymorphism was not associated with differences in percent body fat, despite the ®nding that the allele frequency for the PRO1019pro polymorphism was associated with differences in percent body fat in this population. 18 The third polymorphism investigated, the microsatellite marker in the OB gene, was not associated with Combined effect of polymorphisms in OB and OB-R AM de Silva et al obesity or risk of diabetes in the Nauruan population. An earlier study in Japanese subjects also failed to ®nd a signi®cant relationship between this region of the OB gene and variables associated with obesity. 17 The OB and OB-R genes have been mapped to human chromosomes 7q31.3 and 1p32, respectively. These genes lie in regions identi®ed through genomewide scans as containing loci important in the development of obesity and type 2 diabetes. Strong evidence of linkage has recently been demonstrated for insulin precursors and the OB region. 28 In addition, several studies have also reported linkage between other genetic markers and obesity in humans. In the Quebec Family Study, suggestive linkage was found between markers on human 1p32 ± p22 and body fat and insulin. 6 The aetiologies of diseases such as obesity and diabetes in humans are complex and often involve a combination of both genetic and environmental risk factors. It has been suggested that common polymorphisms may represent genetic risk factors that alone are neither necessary nor suf®cient for a disease to develop, however, in combination these genes may act to predispose an individual to developing the disease. 4 A recent study involving the use of a knock-out mouse model of type 2 diabetes has demonstrated that insulin resistance and diabetes can progressively develop as a result of modest genetic defects. 29 These defects, present at birth, are thought to alter the expression of molecules involved in the insulin signaling cascade. 29, 30 Although the alterations occur in different genes, the combination of these gene defects is thought to act synergistically to initiate a series of metabolic disturbances leading to diabetes through effects on the key components of insulin action. 30 In addition, four loci have been identi®ed that determine obesity in the BSB mouse, a multifactorial model. 5 Individually, these loci have varying effects on the level and distribution of body fat in the animal, however, the effect is dependent on the genotypes at the other loci. The four loci did not appear to act in a simple additive manner, but rather represented complex interactions among a variety of genes. 15 In this study we have demonstrated that Nauruan subjects who have homozygosity for the common alleles of all three sequence polymorphisms investigated had signi®cantly elevated fasting insulin concentrations when compared to individuals in this population without this genetic combination. A recent study in obese Finns demonstrated that subjects with polymorphisms in both uncoupling protein-1 (UCP-1) and b 3 -adrenergic receptor genes had signi®cantly lower basal metabolic rates than subjects with only one of these polymorphisms. 31 This study again highlights the observation that complex gene interactions may manifest themselves physiologically in humans.
The major complication of obesity in Paci®c Island populations, type 2 diabetes, is known to affect approximately one-third of the adult population of Nauru and is associated with much morbidity and mortality. 22 Our study suggests that a speci®c combination of alleles may increase the risk of subsequently developing type 2 diabetes in a proportion of Nauruan males. This allele combination is associated with an elevated fasting insulin concentration, suggesting the presence of insulin resistance. We have uncovered this association in a unique population, characterised by one of the highest prevalence rates for obesity and type 2 diabetes ever reported. Our hypothesis that polymorphisms in the OB and OB-R genes may be involved with the development of insulin resistance in Nauruan males needs to be prospectively con®rmed with the use of metabolic studies.
The relationship described may be absent in other populations either because of different haplotype combinations at the OB-R gene or because the markers tested may not themselves be functional polymorphisms. Whilst the functionality of these polymorphisms needs to be investigated, the lack of physiological functions at these polymorphic sites would not necessarily rule out the possibility of the presence of linkage disequilibrium between these markers and closely linked functional polymorphisms. This may be particularly important for the PRO1019pro polymorphism, in which the nucleotide substitution does not result in an amino acid change. In addition, any other population differences revealed may in part arise through the effects of distinct selection pressures operating historically in Nauru.
An earlier study on the genetic aetiology of type 2 diabetes in Nauru demonstrated that ancestral foreign admixture has a protective effect against diabetes in the Nauruan population. 26 From previous studies we can infer that the non-diabetic population in this study contains a high proportion of individuals that are partrather than full-blooded Nauruans. The majority of Nauruans, however, have no European ancestry and most have diabetes by the age of 60. 26 It has been suggested therefore, that the genes predisposing to diabetes have attained extremely high frequencies in this population, through either the effects of selection or genetic drift. 26 Further studies have revealed that genetic drift is most likely responsible for this genetic concentration due to the extreme geographical isolation of Nauru and the presence of genetic markers in the Nauruan population that are rare or absent in other Asian or Paci®c populations. 26 It has been suggested that inconsistent results observed in linkage studies are a consequence of alleles being either too rare or too prevalent in a second population for linkage to be demonstrated. 6 In addition, allele frequencies reported for these same polymorphisms in different populations are known to differ with ethnicity. 17 ± 20,27 The causes of obesity and type 2 diabetes in the Nauruan population, therefore may be uniquely different to the causes of these diseases in other populations. Nauruans have been demonstrated to have an extraordinarily high Combined effect of polymorphisms in OB and OB-R AM de Silva et al prevalence rate of obesity and diabetes and the unique geographical isolation of the island further compounds genetic predispositions existing in this population. Genetic studies may uncover novel causes of obesity and type 2 diabetes in the Nauruan population and the present study has revealed that insulin resistance in this population may partly be a consequence of alterations in leptin and the OB-R system. The polymorphisms studied may not themselves be functional, however con®rmation of an interaction between OB and OB-R polymorphisms in other populations would add strength to these ®ndings.
